Padeliporfin VTP (brand name Tookad) has previously been approved by the European Union, Israel, and Mexico as a treatment for low-risk prostate cancer, following demonstration of significant clinical ...

Following this standard treatment regimen, the rodents develop recurrent tumors, establishing what is referred to as an ...

A study uncovers intricate details about protein function at the molecular level. The discovery could transform disease diagnostics and treatment.

Prostate cancer is a common type of cancer in males, but it is highly treatable in the early stages. It begins in the prostate gland, which sits between the penis and the bladder. Experts do not ...

If you have HER2-positive breast cancer, your options for treatment will depend on several factors, such as the stage of cancer (early or metastatic) and the hormone receptor status of the tumor. HER2 ...

The research presents valuable findings on the impact of FRMD8 loss on tumor progression and resistance to tamoxifen therapy. Through a series of convincing and systematic experiments, the author ...

that are used in photodynamic therapy (PDT). They destroy metastatic breast cancer tumors. Currently, the research has been done on mice and proven to be effective with few side effects.

The wines will be selected by Sarah Abbott MW, Wine Marketing Consultant, Co-Founder of The Old Vine Conference and IWSC Committee Judge, and Ronan Sayburn MS, CEO of The Court of Master Sommeliers.

Researchers at City of Hope have identified a new molecular target for treating pancreatic cancer and reported on a series of preclinical studies and the first clinical evidence indicating the ...

Citation: Test predicts which patients with prostate cancer most likely to develop long-term side effects from radiation therapy (2025, April 7) retrieved 27 April 2025 from https://medicalxpress ...

Anthony Cannella had twice faced down a rare and aggressive cancer only to see it come back a number of years later. The third time might be the charm for him after he received a refined therapy ...